Bicycle Therapeutics (BCYC) Accumulated Depreciation (2018 - 2024)

Bicycle Therapeutics has reported Accumulated Depreciation for 7 years, with the latest figure at $16.6 million in Q2 2024.

• For the quarter ending Q2 2024, Accumulated Depreciation rose 59.03% year-over-year to $16.6 million; the trailing twelve-month figure through Jun 2024 stood at $16.6 million (up 59.03% YoY), and the FY2023 full-year result was $13.4 million, up 70.33% from the prior year.
• Accumulated Depreciation for Q2 2024 stood at $16.6 million, up from $14.9 million in the prior quarter.
• The five-year high for Accumulated Depreciation was $16.6 million in Q2 2024, with the low at $2.8 million in Q1 2020.
• Historically, Accumulated Depreciation has averaged $7.3 million across 5 years, with a median of $5.1 million in 2022.
• Annual changes were most pronounced in 2022 — Accumulated Depreciation grew 15.09% — and 2023, when it soared 101.58%.
• Bicycle Therapeutics' Accumulated Depreciation stood at $4.0 million in 2020, then advanced by 19.05% to $4.8 million in 2021, then surged by 63.81% to $7.9 million in 2022, then soared by 70.33% to $13.4 million in 2023, then gained by 23.99% to $16.6 million in 2024.
• The last three Accumulated Depreciation figures came in at $16.6 million (Q2 2024), $14.9 million (Q1 2024), and $13.4 million (Q4 2023), per Business Quant data.